0156T0 — HL Genomics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual balance sheet for HL Genomics, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS
Standards:	IFRS	IFRS	IFRS
Status:	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	33,714	33,936	37,684
Net Total Accounts Receivable
Net Total Receivables	5,704	3,852	4,539
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	43,466	46,100	49,633
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	17,395	20,687	24,632
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	71,312	81,818	89,078
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2,902	4,910	4,121
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	4,464	6,603	5,526
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	66,848	75,214	83,552
Total Liabilities & Shareholders' Equity	71,312	81,818	89,078
Total Common Shares Outstanding